platoseedplatoseed
AI Agents for Pharma Drug Launches
Cellbyte's AI agents help pharma companies launch new drugs worldwide. Market-leading firms are using Cellbyte to answer questions like “What price can we achieve for our new drug in the U.S. versus Germany?“. The three co-founders have known and worked with each other for many years: Daniel brings 5+ years of industry experience from his previous job at leading global Life Sciences consultancy Simon-Kucher. Felix has sold $3m+ ACV deals to customers like H&M for his previous YC startup. Samuel holds an MSc in Information Systems from TUM, and has built enterprise AI applications from scratch as ML Engineer at Celonis.
Cellbyte provides an AI-driven workspace for Pricing and Market Access teams in pharma, offering insights across HTA, pricing, and regulatory data to accelerate drug launch planning and evidence-based decisions.
Cellbyte delivers an integrated platform with: Drug Explorer to aggregate global regulatory, HTA, access, and pricing data from 100+ sources; Document Intelligence to extract insights from multilingual documents; Agentic Workflows to deploy AI agents with human-in-the-loop; and Data Vault for secure data uploads and collaboration. It links insights to original sources, supports benchmarking, and enables fast analysis and scenario planning for launch and market access decisions.
Who it’s for: Pricing and Market Access professionals in the pharmaceutical industry
Seed round disclosed (~$2.75M); mentions of platform development, integration capabilities, and enterprise-grade security/compliance
Co-founder & CEO of Cellbyte. We are building AI agents to accelerate the launch and commercialization of pharmaceutical drugs. Pivoted from Last Mile Logistics in 2023: previously co-founded and led Operations at Glocally (W22), where we offered a same-day parcel delivery service to e-commerce brands like H&M. Utilizing electric vehicles only, we surpassed 150K parcels with excellent reviews, and raised >$2M from top-tier Angels and VCs (YC, Trucks,...).
Cellbyte's AI agents help pharma companies launch new drugs worldwide. Market-leading firms are using Cellbyte to answer questions like “What price can we achieve for our new drug in the U.S. versus Germany?“.
Cellbyte builds AI agents and data-powered analytics for pharmaceutical drug launches, offering integrated data, instant analytics, and workflow outputs to optimize pricing and market access across 12 markets, with ongoing expansion and a fundraising round announced for June 2025.
Formerly “Glocally” · why startups rename →
AI for Pharma Intelligence
The world's first AI-maximalist pharma company
